Primary optic nerve sheath meningioma: Stereotactic fractionated radiation therapy as an emerging treatment of choice

Cancer

Volumn 110, Issue 4, 2007, Pages 714-722

  Jeremic, Branislav ^a   Pitz, Susanne ^b  

^a INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Optic nerve sheath meningioma; Stereotactic fractionated radiation therapy; Visual acuity; Visual fields

Indexed keywords

PENTETREOTIDE IN 111;

ARTICLE; BLINDNESS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DRY EYE; EXCISION; EXTERNAL BEAM RADIOTHERAPY; EYE PAIN; FENESTRATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRITIS; MENINGIOMA; NERVE SHEATH TUMOR; OBSERVATION; OPHTHALMOSCOPY; OPTIC NERVE SHEATH MENINGIOMA; OPTIC NEURITIS; PRIORITY JOURNAL; RADIATION INJURY; RETINOPATHY; SCINTIGRAPHY; STEREOTACTIC FRACTIONATED RADIOTHERAPY; VITREOUS HEMORRHAGE;

DOSE FRACTIONATION; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NERVE SHEATH NEOPLASMS; OPTIC NERVE NEOPLASMS; RADIOTHERAPY, CONFORMAL; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 34547865003     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22859     Document Type: Article

References (85)

1. Dutton JJ. Optic nerve sheath meningioma. Surv Ophthalmol. 1992;37:167-183.
2. Gabibov G, Blinkov SM, Tcherekayev VA. The management of optic nerve meningiomas and gliomas. J Neurosurg. 1988;68:889-893.
3. Sibony PA, Krauss HR, Kennerdell JS, Maroon JC, Slamovits TL. Optic nerve sheath meningioma: clinical manifestations. Ophthalmology. 1984;91:1313-1324.
4. Wright JE, Call NB, Liaricos S. Primary optic nerve meningioma. Br J Ophthalmol. 1980;64:553-558.
5. D'Alena PR. Primary orbital meningioma. Arch Ophthalmol. 1964;71:832-836.
6. Rootman J. Diseases of the Orbit. A Multidisciplinary Approach. London: JB Lippincott; 1988:281-285.
7. Craig WM, Gogela LJ. Intraorbital meningiomas. A clinicopathologic study. Am J Ophthalmol. 1949;32:1663-1680.
8. Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am J Ophthalmol. 1988;106:450-457.
9. Sarkies NJC. Optic nerve sheath meningioma: diagnostic features and therapeutic alternatives. Eye. 1987;1:597-602.
10. Swenson SA, Forbes GS, Younge BR, Campbell RJ. Radiologic evaluation of tumors of the optic nerve. AJNR. 1982;3:319-326.
11. Wilson WB. Meningiomas of the anterior visual system. Surv Ophthalmol. 1981;26:109-127.
12. Sibony PA, Kennerdell JS, Slamovits TL, Lessell S, Krauss HR. Intrapapillary refractile bodies in the optic nerve sheath meningioma. Arch Ophthalmol. 1985;103:383-385.
13. Alper MG. Management of primary optic nerve meningiomas. J Clin Neuroophthalmol. 1981;1:101-117.
14. Ito M, Ishizawa A, Miyaoka M Sato K, Ishii S. Intraorbital meningiomas. Surgical management and role of radiation therapy. Surg Neurol. 1988;29:448-453.
15. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J Ophthalmol. 1989;73:960-966.
16. Gans MS, Frazier Byrne S, Glaser JS. Standardized A-scan echography in optic nerve disease. Arch Ophthalmol. 1987;105:1232-1236.
17. Karp LA, Zimmerman LE, Borit A, Spencer W. Primary intraorbital meningioma. Arch Ophthalmol. 1974;91:24-28.
18. Ellenberger C. Perioptic meningiomas. Arch Neurol. 1976;33:671-674.
19. Daniels DL, Williams AL, Syvertsen A, Gager WE, Harris GJ. CT recognition of optic nerve sheath meningioma: abnormal sheath visualization. AJNR. 1982;3:181-183.
20. Mafee MF. Eye and orbit. In: Som PM, Curtin HD, eds. Head and Neck Imaging. St. Louis: Mosby; 1996:1009.
21. Mafee MF. Orbit and globe. In: Valvassori GE, Mafee MF, Carter BL, eds. Imaging of the Head and Neck. Stuttgart: Thieme Medical; 1996:157.
22. Dutton JJ, Anderson RL. Idiopathic inflammatory perioptic neuritis simulating optic sheath meningioma. Am J Ophthalmol. 1985;100:424-430.
23. Ing EB, Garrity JA, Cross SA, Ebersold MJ. Sarcoid masquerading as optic nerve sheath meningioma. Mayo Clin Proc. 1997;72:38-43.
24. Cornblath WT, Quint WJ. MRI of optic nerve enlargement in optic neuritis. Neurology 1997;48:821-826.
25. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology. 1997;104:1634-1643.
26. Krohel GB, Charles H, Smith RS. Granulomatous optic neuropathy. Arch Ophthalmol. 1981;99:1053-1055.
27. Lee AG. Postoperative irradiation. Ophthalmology. 1997;104:898.
28. Smith JL, Vuksanovic MM, Yates BM, Bienfang DC. Radiation therapy for primary optic nerve meningiomas. J Clin Neuroophthalmol. 1981;1:85-99.
29. Arnold AC, Hepler RS, Badr MA, et al. Metastasis of adenocarcinoma of the lung to optic nerve sheath meningioma. Arch Ophthalmol. 1995;113:346-351.
30. Balcer LJ, Galetta SL, Curtis M, Maguire A, Judy K. von Hippel-Lindau disease manifesting as a chiasmal syndrome. Surv Ophthalmol. 1995;39:302-306.
31. Hashimoto M, Tomura N, Watarai J. Retrobulbar orbital metastasis mimicking meningioma. Radiat Med. 1995;13:77-79.
32. Mafee MF. Orbital and ocular lesions. In: Edelman RR, Hesselink JR, Zlatkin MB, eds. Clinical Magnetic Resonance Imaging. Philadelphia: WB Saunders; 1996:985.
33. Andrews DW, Faroozan R, Yang BP, et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002;51:890-904.
34. Garcia JP Jr, Finger PT, Kurli M, Holliday RA. 3D ultrasound coronal C-scan imaging for optic nerve sheath meningioma. Br J Ophthalmol. 2005;89:244-245.
35. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd ed. Berlin: Springer; 1993.
36. Maier H, Ofner D, Hittmaier A, et al. Classic, atypical, and anaplastic meningioma: three histopathological subjects of clinical relevance. J Neurosurg. 1996;77:616-623.
37. Greenberg HS. Meningiomas. In: Gilman S, Goldstein GW, Waxman SG, eds. Neurobase. 1st ed. San Diego: Arbor; 1998.
38. Chamberlain MC. Meningiomas. Curr Treat Options Neurol. 2001;3:67-76.
39. Kyritsis AP. Chemotherapy for meningioma. J Neurooncol. 1996:29:269-272.
40. Paus S, Kolckgether T, Urbach H, et al. Meningioma of the optic nerve sheath: treatment with hydroxyurea. J Neurol Neurosurg Psychiatry. 2003;74:1348-1350.
41. Turbin RE, Pokorny K. Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control. 2004;11:334-341.
42. Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningioma. Arch Ophthalmol. 2002;120:1505-1508.
43. Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology. 2002;109:890-899.
44. Miller NR. Orbital tumor. In: Long DM, ed. Current Therapy in Neurological Surgery. St. Louis: CV Mosby; 1985:5-7.
45. Wright JE. Primary optic nerve meningiomas: clinical presentation and management. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:617-625.
46. Byers WGM. Tumors of the optic nerve. JAMA. 1914;63:20-25.
47. Durante F. Contribution to endocranial surgery. Lancet. 1887;2:654-655.
48. Cushing H, Eisenhardt L. Meningiomas: Their Classification, Regional behavior, Life History, and Surgical End Results. Springfield, IL: Charles C. Thomas; 1938:250-282.
49. Dandy WE. Results following transcranial operative attack on orbital tumors. Arch Ophthalmol. 1941;25:749.
50. Wilson GH, Byfield J, Hanafee WN. Atrophy following radiation therapy for central nervous system neoplasms. Acta Radiol (Stockh). 1972;11:361-368.
51. Blodi FC, Brailey AE. Primary and secondary meningiomas of the orbit. Ophtalmologica. 1966;151:760-764.
52. Ebers CG, Girvin JP, Canny CB. A possible optic nerve meningioma. Arch Neurol. 1980;37:781-783.
53. Mark LE, Kennerdell JS, Maroon JC, Rosenbaum AE, Heinz R, Johnson BL. Microsurgical removal of a primary intraorbital meningioma. Am J Ophthalmol. 1978;86:704-709.
54. Cristante L. Surgical treatment of meningiomas of the orbit and optic canal: a retrospective study with particular attention to the visual outcome. Acta Neurochir. 1994;126:27-32.
55. Delfini R, Missori P, Tarantino R, Ciappetta P, Cantore G. Primary benign tumors of the orbital cavity: comparative data in a series of patients with optic nerve glioma, sheath meningioma, or neurinoma. Surg Neurol. 1996;45:147-153.
56. Dabbs CB, Kline LB. Big muscles and big nerves. Surv Ophthalmol. 1997;42:247-254.
57. Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86:1265-1268.
58. Liu JK, Forman S, Hershewe GL, Moorthy CR, Benzil DL. Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy. Neurosurgery. 2002;50:950-957.
59. Becker G, Jeremic B, Pitz S, et al. Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2002;54:1422-1429.
60. Kupersmith MJ, Warren FA, Newall J, Ransohoff J. Irradiation of meningiomas of the intracranial anterior visual pathway. Ann Neurol. 1987;21:131-137.
61. Mondon H, Hamard J, Sales D. Place de la radiotherapie dans le traitment des meningiomes du nerf optique. Bull Soc Ophthalmol Fr. 1985;85:379-382.
62. Dyke CG, Davidoff LM. Roentgen Treatment of Diseases of the Nervous System. Philadelphia: Lea and Febiger; 1942: 113.
63. Simpson D. Recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20:22-39.
64. Becker G, Kocher M, Kortmann RD, et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol. 2002;178:173-186.
65. Brada M, Rajan B, Traish D, et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol. 1993;38:571-578.
66. Goldsmith BJ, Rosenthal SA, Wara WM, Larson DA. Optic neuropathy after irradiation of meningioma. Radiology. 1992;185:71-76.
67. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:755-763.
68. Eng T, Albright N, Kuwahara G, et al. Precision radiation therapy for optic nerve sheath meningiomas. Int J Radiat Oncol Biol Phys. 1992;22:1093-1098.
69. Lee AG, Woo SY, Miller NR, Safran AB, Grant WH, Butler EB. Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with three-dimensional conformal irradiation therapy. J Neuroophthalmol. 1996;16:247-251.
70. Klink DF, Miller NR, Williams J. Preservation of residual vision 2 years after stereotactic radiosurgery for a presumed optic nerve sheath meningioma. J Neuroophthalmol. 1998;18:117-120.
71. Grant W III, Cain RB. Intensity modulated conformal therapy for intracranial lesions. Med Dosim. 1998;2 3:237-241.
72. Fineman MS, Augsburger JJ. A new approach to an old problem. Surv Ophthalmol. 1999;3:519-524.
73. Moyer PD, Golnik KC, Breneman J. Treatment of optic nerve sheath meningioma with three-dimensional conformal radiation. Am J Ophthalmol. 2000;129:694-696.
74. Narayan S, Cornblath WT, Sandler HM, et al. Preliminary visual outcomes after three-dimensional conformal ration therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2003;56:537-543.
75. Schick U, Dott U, Hassler W. Surgical management of meningiomas involving the optic nerve sheath. J Neurosurg. 2004;10:951-959.
76. Roser F, Nakamura M, Martini-Thomas R, Samii M, Tatagiba M. The role of surgery in meningiomas involving the optic nerve sheath. Clin Neurol Neurosurg. 2006;108:470-476.
77. Vagefi MR, Larson DA, Horton JC. Optic nerve sheath meningioma: visual improvement during radiation treatment. Am J Ophthalmol. 2006;142:343-344.
78. Baumert BG, Villa S, Studer G, et al. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol. 2004;72:169-174.
79. Richards JC, Roden D, Harper CS. Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin Exp Ophthalmol. 2005;33:137-141.
80. Landert M, Baumert B, Bosch MM, Lutolf U, Landau K. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophthalmol. 2005;25:86-91.
81. Paridaens ADA, van Ruyven RLJ, Eijkenboom WMH, Mooy CM, van den Bosch WA. Stereotactic irradiation of biopsy proved optic nerve sheath meningioma. Br J Ophthalmol. 2006:246-247.
82. Sitathanee C, Dhanachai M, Poonyathalang A, Tuntiyatorn L, Theerapancharoen S. Stereotactic radiation therapy for optic nerve sheath meningioma: an experience at Ramathibodi hospital. J Med Assoc Thai. 2006;89:1665-1669.
83. Subramanian PS, Brssler NM, Miller NR. Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma. Ophthalmology. 2004;111:565-567.
84. Uy NW, Woo SY, The BS, et al. Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys. 2002;53:1265-1270.
85. Saeed P, Rootman J, Nugent RA, et al. Optic nerve sheath meningiomas. Ophthalmology. 2003;110:2019-2030.